【摘要】 目的:观察产前应用氨溴索预防早产儿呼吸窘迫综合征的疗效。方法:将152例早产孕妇随机分为两组,即治疗组和对照组。对照组单纯应用地塞米松;观察组在常规应用地塞米松的基础上加用氨溴索。比较用药后两组早产儿NRDS的发生情况。结果:观察组NRDS患病率为5.26%,对照组患病率为21.05%。观察组患病率明显低于对照组,差异有统计学意义。结论:产前应用氨溴索能明显降低早产儿NRDS的发病率,且可降低早产儿的感染发生率。更多还原

【Abstract】 Objective: To observe the clinical effect of antenatal Ambroxol usage in the prevention of premature infants respiratory distress syndrome. Methods: 152 cases of premature delivery in pregnant women were randomly divided into two groups, the observation group and control group. The control group treated with Dexamethasone , and the observation group treated with Ambroxol on the basis of the conventional application of Dexamethasone. The incidence of NRDS in these two groups was compared after the treatment. Results: The rate of NRDS in the observation group (5.26%) was significantly lower than that in the control group (21.05%). Conclusion: Antenatal Ambroxol usage can reduce the rate of NRDS and reduce the infection rate on the premature infants.更多还原